Autoimmune Diseases
Pain, Misdiagnosis, and Autoimmune Disease: Untangling Complexity and Bias
David Alvaro, Ph.D.; Chia Chia Sun
Pharma's Almanac
PAO-08-25-CL-03Aug 06, 2025
CRISPR
Startup Navega Therapeutics Aims to Develop a CRISPR Treatment for Pain
Emilie Branch
Pharma's Almanac
PAO-M09-19-NI-008Sep 04, 2019
Pain Management
Using a Scorpion Toxin to Study Pain and Inflammation
Emilie Branch
Pharma's Almanac
PAO-M00-19-NI-002Sep 04, 2019
Pain Management
Heron Announces European Medicines Agency Validation of Marketing Authorisation Application for HTX-011 for Postoperative Pain Management
Heron Therapeutics, Inc.
PR-M04-19-NI-026Apr 08, 2019
Clinical Trials
Late-Stage Positive Results Reported for Nerve Growth Factor Inhibitor
Nice Insight
PAO-M02-19-NI-017Feb 21, 2019
FDA Approval
AcelRx Announces FDA Approval of DSUVIA™
Talphera Inc.
PR-M11-18-NI-017Nov 06, 2018
Licensing Agreement
Grünenthal Acquires Global Rights for Qutenza®
Grünenthal Group
PR-M11-18-NI-020Nov 06, 2018
Phase 3
PainReform Gets FDA Approval for Phase III Post-Operative Pain Relief Study
PainReform Ltd
PR-M07-18-NI-062Jul 19, 2018
Clinical Trials
Centrexion Therapeutics Raises $67 Million; Launching Phase 3 Program for CNTX-4975 in Knee Osteoarthritis Pain in 2018
Centrexion Therapeutics
PR-M01-18-NI-002Jan 02, 2018
Non-Opioid
SiteOne Therapeutics Garners US Department of Defense Award
Emilie Branch
Pharma's Almanac
PAO-M11-17-NI-036Nov 21, 2017
Pain Management
The Cost of Pain
Guy Tiene
Nice Insight
PAO-M05-17-NI-027May 23, 2017